PDXK and breast cancer: Importantly, in our present study, butyrate treatment upregulates the expression of PDXK and SLC25A28 in cellular and animal experiments, suggesting a potential inhibitory effect of butyrate on BC development through the regulation of cuproptosis or cuproptosis-related genes.